Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Development as Anti-Leukemic Agents, a Novel Synthesis of Phospha Sugar Derivatives in Therapy for Leukemias, and Analysis of Their Characterizations.

Satoki Nakamura, MD, PhD, Keiji Okinaka, MD, Isao Hirano, MD, Takaaki Ono, MD, Kazuyuki Shigeno, MD, Kaori Shinjo, MD,PhD, Michio Fujie, Yukiko Iguchi, PhD, Taishi Niimi, PhD, Satoru Ito, PhD, Takuya Suyama, PhD, Kazuhide Asai, PhD, Mitsuji Yamashita, PhD, Kazunori Ohnishi, MD, PhD

Blood (2007) 110 (11): 4174.

https://doi.org/10.1182/blood.V110.11.4174.4174

Published: 2007

Journal Articles

Bcr-Abl Inhibitors Induce Expression of HoxA10, Playing a Role as an Inhibitor of the Proliferation through PI3K/PKB Pathway in Chronic Myelogenous Leukemia Cells.

Yuya Sugimoto, MD, Satoki Nakamura, MD,PhD, Takaaki Ono, MD, Miki Kobayashi, MD,PhD, Naohi Sahara, MD,PhD, Kaori Shinjo, MD,PhD, Kazuyuki Shigeno, MD,PhD, Kazunori Ohnishi, MD,PhD

Blood (2006) 108 (11): 1363.

https://doi.org/10.1182/blood.V108.11.1363.1363

Published: 2006

Journal Articles

Analysis of Aurora Kinase Expressions and Cell Cycle Regulation by Aurora-C in Leukemia Cells.

Miki Kobayashi, MD, PhD, Satoki Nakamura, MD, PhD, Takaaki Ono, MD, Yuya Sugimoto, MD, Naohi Sahara, MD, PhD, Kaori Shinjo, MD, PhD, Kazuyuki Shigeno, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2006) 108 (11): 1366.

https://doi.org/10.1182/blood.V108.11.1366.1366

Published: 2006

Journal Articles

Analysis of the Expression of an Endogenous Tumor Suppressor Gene, PHLPP, and Elevation of PHLPP as an Ideal Target for MRD Monitoring in Leukemia.

Takaaki Ono, MD, Satoki Nakamura, MD,PhD, Yuya Sugimoto, MD, Miki Kobayashi, MD,PhD, Naohi Sahara, MD,PhD, Kaori Shinjo, MD,PhD, Kazuyuki Shigeno, MD,PhD, Shinya Fujisawa, MD, Kazunori Ohnishi, MD,PhD

Blood (2006) 108 (11): 4327.

https://doi.org/10.1182/blood.V108.11.4327.4327

Published: 2006

Journal Articles

Analysis of FoxM1 Expression and Regulation of Cell Cycle, and Anti-Leukemic Effectss by FoxM1 Knockdown on Leukemia Cells Transfected with siRNA FoxM1.

Satoki Nakamura, MD, PhD, Takaaki Ono, MD, Yuya Sugimoto, MD, Miki Kobayashi, MD,PhD, Naohi Sahara, MD,PhD, Kazuyuki Shigeno, MD,PhD, Kaori Shinjo, MD,PhD, Shinya Fujisawa, MD,PhD, Kazunori Ohnishi, MD,PhD

Blood (2006) 108 (11): 4320.

https://doi.org/10.1182/blood.V108.11.4320.4320

Published: 2006

Journal Articles

Elevation of Kinase Interacting with Stathmin (KIS) and Promotion of Cellcycle Progression by KIS in Leukemia Cells.

Satoki Nakamura, MD, PhD, Takaaki Ono, MD., Yuya Sugimoto, MD., Miki Kobayashi, MD., Naohi Sahara, MD.PhD, Kaori Shinjo, MD.PhD, Kazuyuki Shigeno, MD.PhD, Kazunori Ohnishi, MD.PhD

Blood (2005) 106 (11): 1365.

https://doi.org/10.1182/blood.V106.11.1365.1365

Published: 2005

Journal Articles

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Miki Kobayashi, MD, Satoki Nakamura, MD, PhD, Kiyoshi Shibata, Naohi Sahara, MD, PhD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2005) 106 (11): 4825.

https://doi.org/10.1182/blood.V106.11.4825.4825

Published: 2005

Journal Articles

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Satoki Nakamura, MD, PhD, Miki Kobayashi, MD, Kiyoshi Shibata, Naohi Sahara, MD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2004) 104 (11): 4836.

https://doi.org/10.1182/blood.V104.11.4836.4836

Published: 2004

NARROW

Development as Anti-Leukemic Agents, a Novel Synthesis of Phospha Sugar Derivatives in Therapy for Leukemias, and Analysis of Their Characterizations.

Bcr-Abl Inhibitors Induce Expression of HoxA10, Playing a Role as an Inhibitor of the Proliferation through PI3K/PKB Pathway in Chronic Myelogenous Leukemia Cells.

Analysis of Aurora Kinase Expressions and Cell Cycle Regulation by Aurora-C in Leukemia Cells.

Analysis of the Expression of an Endogenous Tumor Suppressor Gene, PHLPP, and Elevation of PHLPP as an Ideal Target for MRD Monitoring in Leukemia.

Analysis of FoxM1 Expression and Regulation of Cell Cycle, and Anti-Leukemic Effectss by FoxM1 Knockdown on Leukemia Cells Transfected with siRNA FoxM1.

Elevation of Kinase Interacting with Stathmin (KIS) and Promotion of Cellcycle Progression by KIS in Leukemia Cells.

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only